MADRIGAL PHARMACEUTICALS INC's ticker is and the CUSIP is 558868955. A total of 5 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,897,576 | -26.1% | 129,400 | +16.9% | 0.06% | -23.2% |
| Q2 2023 | $25,571,700 | +163.9% | 110,700 | +176.8% | 0.08% | +134.3% |
| Q1 2023 | $9,690,400 | -64.6% | 40,000 | -57.6% | 0.04% | -45.3% |
| Q4 2022 | $27,370,575 | +1867.7% | 94,300 | +340.7% | 0.06% | +2033.3% |
| Q3 2022 | $1,391,000 | -7.5% | 21,400 | +1.9% | 0.00% | +50.0% |
| Q2 2022 | $1,503,000 | +14930.0% | 21,000 | +20900.0% | 0.00% | – |
| Q1 2022 | $10,000 | -98.2% | 100 | -98.5% | 0.00% | – |
| Q4 2021 | $559,000 | +3393.8% | 6,600 | +3200.0% | 0.00% | – |
| Q3 2021 | $16,000 | +60.0% | 200 | +100.0% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | +9.1% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | -95.8% | 100 | -96.7% | 0.00% | -100.0% |
| Q3 2019 | $259,000 | +7.5% | 3,000 | +30.4% | 0.00% | 0.0% |
| Q2 2019 | $241,000 | -26.1% | 2,300 | -11.5% | 0.00% | -50.0% |
| Q1 2019 | $326,000 | -21.8% | 2,600 | -29.7% | 0.00% | 0.0% |
| Q4 2018 | $417,000 | +561.9% | 3,700 | -26.0% | 0.00% | +300.0% |
| Q3 2016 | $63,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 129,400 | $18,897,576 | 0.06% |
| JANE STREET GROUP, LLC | 194,300 | $28,375,572 | 0.01% |
| SIMPLEX TRADING, LLC | 15,200 | $2,219 | 0.00% |
| JPMORGAN CHASE & CO | 115,700 | $16,896,828 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |